Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial Todd M. Dewey, MD, Bruce Bowers, MD, Vinod H. Thourani, MD, Vasilis Babaliaros, MD, Craig R. Smith, MD, Martin B. Leon, MD, Lars G. Svensson, MD, PhD, E. Murat Tuzcu, MD, D. Craig Miller, MD, Paul S. Teirstein, MD, Jeffrey Tyner, MD, David L. Brown, MD, Gregory P. Fontana, MD, Raj R. Makkar, MD, Mathew R. Williams, MD, Isaac George, MD, Ajay J. Kirtane, MD, MS, Joseph E. Bavaria, MD, Michael J. Mack, MD The Annals of Thoracic Surgery Volume 96, Issue 6, Pages 2083-2089 (December 2013) DOI: 10.1016/j.athoracsur.2013.05.093 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier time-to-event curves for all-cause mortality. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier time-to-event curves for stroke. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier time-to-event curves for the composite end point of all-cause mortality or stroke. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 New York Heart Association functional status among survivors. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery 2013 96, 2083-2089DOI: (10.1016/j.athoracsur.2013.05.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions